Your search for ‘Potter Clarkson’ returned 396 results

The COVID-19 pandemic thrust mRNA technology into the global spotlight, transforming decades of foundational research into commercially valuable vaccines almost overnight. This rapid commercialization, combined with enormous revenues and a complex web of overlapping patents, has triggered an unprecedented wave of intellectual property disputes that is reshaping how value is allocated across the biotechnology industry and determining who controls access to next-generation RNA-based medicines.

The UK Supreme Court has brought welcome clarity to the patentability of software and AI inventions by adopting the European Patent Office's "any hardware" approach and moving away from the long‑standing Aerotel test.

The implementation of the Windsor Framework on 1 January 2025 marked a significant turning point in the UK's regulatory landscape for human medicines.

Following our previous post regarding the public consultation recently carried out by the UK Intellectual Property Office (UK IPO or IPO)

An Advocate General of the Court of Justice of the EU has handed down his non-binding opinion on the interpretation of EU law about supplementary protection certificates for combination medicinal products.

The European Health Data Space (EHDS) regulation has entered into force, creating a harmonised framework for cross-border health data access across the EU. While Europe possesses exceptional health data resources—particularly in Nordic countries with comprehensive patient registries—it has historically lacked the commercial data market infrastructure seen in the United States. This analysis explores how life science companies and investors can position themselves to capitalise on emerging opport

This article explores how a well‑structured intellectual property strategy underpins every ambitious fashion business, protecting everything from brand identity to innovative materials and manufacturing techniques.

Counterfeit products are everywhere. According to the US National Crime Prevention Council, it is now an industry that boasts an annual turnover of $2 trillion...

Standards ensure the interoperability of products relating to the same technology from different manufacturers.

It includes the activities of your competitors in terms of their pending and granted rights and can also reveal information about the direction of their R&D focus.

Biotechnology and chemistry startups face a critical question when filing priority patent applications: how much experimental data is actually required? While the answer depends on the predictability of the technology, the European Patent Office's strict disclosure standards mean that insufficient technical support can invalidate priority claims entirely, leaving innovations vulnerable to competitor filings and prior art that emerges during the assumed protection period.

The traditional understanding of copyright protection is built on the principle that authors and rightsholders possess the exclusive power to control how their works are used, reproduced...

According to data released in March by the World Intellectual Property Office, WIPO, Huawei, Samsung and Qualcomm retained their positions as the top three filers of international patent applications filed in 2023.

In April 2023, the European Commission adopted a comprehensive package of proposed reforms to the legislation governing the authorisation of medicines in the EU.